About Covalon Technologies (CVE:COV)
Covalon Technologies Ltd. researches, develops, manufactures, markets, and licenses medical products in the areas of advanced wound care, infection management, and surgical procedures worldwide. The company offers Collagen Matrix platform to develop products for the treatment of donor and graft sites, traumatic and surgical wounds, and first and second degree burns, as well as diabetic, pressure, and venous ulcers; Antimicrobial Silicone Adhesive platform, a pre-surgical, post-surgical, and vascular access products; and medical coating platform CovaCoat, a technology that provides photochemical process for covalently linking coating molecules to various medical device surfaces. Its medical coatings deliver infection control, therapeutic delivery, and lubricity. The company also provides services, such as feasibility studies, product formulation, prototype testing, validation, regulatory clearances, and manufacturing. In addition, it offers wound care products comprising ColActive Plus Ag collagen matrix dressings; ColActive Transfer wound contact layers; and CovaWound advanced wound care dressings. Further, the company provides IV Clear and SurgiClear antimicrobial silicone dressings. It offers its technologies, products, and services to medical device companies; healthcare providers, such as hospitals, wound care centers, burn centers, extended/alternate care facilities, acute care facilities, home health care agencies, and physicians offices; and individual consumers. Covalon Technologies Ltd. is headquartered in Mississauga, Canada.
Industry, Sector and Symbol:
- Industry: Biotechnology
- Sub-Industry: N/A
- Sector: Healthcare
- Symbol: CVE:COV
- CUSIP: N/A
- Web: www.covalon.com
- Trailing EPS: C($0.05)
- Net Margins: 9.17%
- Return on Equity: 31.45%
- Return on Assets: 22.05%
- Outstanding Shares: 21,342,000
Frequently Asked Questions for Covalon Technologies (CVE:COV)
What is Covalon Technologies' stock symbol?
Covalon Technologies trades on the Canadian Venture Exchange (CVE) under the ticker symbol "COV."
When will Covalon Technologies make its next earnings announcement?
Who are some of Covalon Technologies' key competitors?
Some companies that are related to Covalon Technologies include Anavex Life Sciences Corp. (AVXL), Trillium Therapeutics (TRIL), Aevi Genomic Medicine (GNMX), ContraFect Corporation (CFRX), Concordia International Corp (CXR), Soligenix (SNGX), Senesco Technologies (SVON), Mateon Therapeutics (MATN), Windtree Therapeutics (WINT), Affymax (AFFY), TetraLogic Pharmaceuticals Corporation (TLOG), Cubist Pharmaceuticals (CBST), Idenix Pharmaceuticals (IDIX) and Onyx Pharmaceuticals (ONXX).
Who are Covalon Technologies' key executives?
Covalon Technologies' management team includes the folowing people:
- Abe Schwartz, Chairman of the Board
- Brian E. Pedlar, President, Chief Executive Officer, Director
- Danny Brannagan, Chief Financial Officer
- Valerio DiTizio, Chief Scientific Officer
- Kim Crooks, Vice President - Operations
- John Hands, Senior Director - Global Marketing
- Elinor Caplan, Director
- Gale Pollock, Director
- Martin C. Bernholtz, Independent Director
- Ian David Brindle, Independent Director
How do I buy Covalon Technologies stock?
Shares of Covalon Technologies and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.
What is Covalon Technologies' stock price today?
One share of Covalon Technologies stock can currently be purchased for approximately C$4.50.
How big of a company is Covalon Technologies?
Covalon Technologies has a market capitalization of C$96.61 million.
How can I contact Covalon Technologies?
Covalon Technologies' mailing address is 1660 Tech Ave Unit 5, MISSISSAUGA, ON L4W 5S7, Canada. The company can be reached via phone at +1-905-5688400.
MarketBeat Community Rating for Covalon Technologies (CVE COV)MarketBeat's community ratings are surveys of what our community members think about Covalon Technologies and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Analysts' Consensus Rating for Covalon Technologies (CVE:COV) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus analyst ratings for company stocks using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||0 Sell Ratings, 0 Hold Ratings, 0 Buy Ratings, 0 Strong Buy RatingsNo ratings tracked in the last 12 months.|
|Consensus Rating:||N/A (Score: NaN)|
|Analysts' Consensus Price Target: ||N/A|
Consensus Price Target History for Covalon Technologies (CVE:COV)
Analysts' Ratings History for Covalon Technologies (CVE:COV)
No equities research coverage for this company has been tracked by MarketBeat.com
Earnings History for Covalon Technologies (CVE:COV)
No earnings announcements for this company have been tracked by MarketBeat.com
Earnings Estimates for Covalon Technologies (CVE:COV)
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for Covalon Technologies (CVE:COV)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for Covalon Technologies (CVE COV)
No insider trades for this company have been tracked by MarketBeat.com
Headline Trends for Covalon Technologies (CVE:COV)
Latest Headlines for Covalon Technologies (CVE COV)
Financials are not available for this stock.
Covalon Technologies (CVE COV) Chart for Saturday, November, 18, 2017